Abessolo H - Search Results

Year	Number of Results
2001	1
2014	1
2015	2
2016	1
2017	1
2018	3
2019	2
2020	2
2021	1
2024	1

1

Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM).

Liégeois F, Eymard-Duvernay S, Boyer S, Maradan G, Kouanfack C, Domyeum J, Boyer V, Mpoudi-Ngolé E, Spire B, Delaporte E, Vidal L, Kuaban C, Laurent C; EVOLCAM study group. Liégeois F, et al. HIV Med. 2019 Jan;20(1):38-46. doi: 10.1111/hiv.12681. Epub 2018 Oct 25. HIV Med. 2019. PMID: 30362279 Free article.

2

Individual and healthcare supply-related barriers to treatment initiation in HIV-positive patients enrolled in the Cameroonian antiretroviral treatment access programme.

Coulaud PJ, Protopopescu C, Ndiaye K, Baudoin M, Maradan G, Laurent C, Spire B, Vidal L, Kuaban C, Boyer S; EVOLCam Group. Coulaud PJ, et al. Health Policy Plan. 2021 Mar 26;36(2):137-148. doi: 10.1093/heapol/czaa153. Health Policy Plan. 2021. PMID: 33367696 Free article.

3

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.

Ciaffi L, Koulla-Shiro S, Sawadogo A, le Moing V, Eymard-Duvernay S, Izard S, Kouanfack C, Ngom Gueye NF, Fobang AA, Reynes J, Calmy A, Delaporte E; 2LADY Study Group. Ciaffi L, et al. AIDS. 2015 Jul 31;29(12):1473-81. doi: 10.1097/QAD.0000000000000709. AIDS. 2015. PMID: 26244387 Free PMC article. Clinical Trial.

4

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).

Liégeois F, Boyer S, Eymard-Duvernay S, Carrieri P, Kouanfack C, Domyeum J, Maradan G, Ducos J, Mpoudi-Ngolé E, Spire B, Delaporte E, Kuaban C, Vidal L, Laurent C; EVOLCAM study group. Liégeois F, et al. BMC Infect Dis. 2020 Jan 15;20(1):49. doi: 10.1186/s12879-020-4784-7. BMC Infect Dis. 2020. PMID: 31941464 Free PMC article.

5

Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.

Galy A, Ciaffi L, Le Moing V, Eymard-Duvernay S, Abessolo H, Toby R, Ayangma L, Le Gac S, Mpoudi-Etame M, Koulla-Shiro S, Delaporte E, Cournil A; 2LADY Study Group. Galy A, et al. Among authors: abessolo h. Antivir Ther. 2016;21(6):547-552. doi: 10.3851/IMP3030. Epub 2016 Feb 16. Antivir Ther. 2016. PMID: 26882335 Clinical Trial.

6

Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.

Boyer S, Nishimwe ML, Sagaon-Teyssier L, March L, Koulla-Shiro S, Bousmah MQ, Toby R, Mpoudi-Etame MP, Ngom Gueye NF, Sawadogo A, Kouanfack C, Ciaffi L, Spire B, Delaporte E; 2-Lady Group. Boyer S, et al. Pharmacoecon Open. 2020 Mar;4(1):45-60. doi: 10.1007/s41669-019-0157-9. Pharmacoecon Open. 2020. PMID: 31273686 Free PMC article.

7

In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites.

Delhaes L, Abessolo H, Biot C, Berry L, Delcourt P, Maciejewski L, Brocard J, Camus D, Dive D. Delhaes L, et al. Among authors: abessolo h. Parasitol Res. 2001 Mar;87(3):239-44. doi: 10.1007/s004360000317. Parasitol Res. 2001. PMID: 11293573

8

Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs.

Chabrol F, Noah Noah D, Tchoumi EP, Vidal L, Kuaban C, Carrieri MP, Boyer S; EVOLCam group. Chabrol F, et al. BMJ Open. 2019 Mar 20;9(3):e025415. doi: 10.1136/bmjopen-2018-025415. BMJ Open. 2019. PMID: 30898817 Free PMC article.

9

High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors.

Tejiokem MC, Abessolo HA, Nkodo JM, Ouethy M, Mayaka GB, Touha Y, Dikoume UA, Tchatchueng-Mbougua JB, Noumbissi DC, Ndjeukam WT, Mbarga HOO, Ngoupo PAT, Moussi C, Garoua BH, Njouom R, Richard V. Tejiokem MC, et al. Among authors: abessolo ha. Influenza Other Respir Viruses. 2024 Feb;18(2):e13239. doi: 10.1111/irv.13239. Influenza Other Respir Viruses. 2024. PMID: 38342486 Free PMC article.

10

Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon - Trial ANRS-12286/MOBIDIP.

Galy A, Ciaffi L, Mberyo GM, Mbouyap P, Abessolo H, Toby R, Essomba F, Lamarre G, Bikié A, Bell O, Koulla-Shiro S, Delaporte E. Galy A, et al. Among authors: abessolo h. Patient Educ Couns. 2018 Jul;101(7):1262-1269. doi: 10.1016/j.pec.2018.01.021. Epub 2018 Feb 1. Patient Educ Couns. 2018. PMID: 29433950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year